We are live on ! Find out more
BFS

Bradley Foster & Sargent Portfolio holdings

AUM $6.44B
1-Year Est. Return 25.27%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+25.27%
3 Year Est. Return
+77.25%
5 Year Est. Return
+101.72%
10 Year Est. Return
–
AUM
$4.26B
AUM Growth
-$20.1M
Cap. Flow
-$50.3M
Cap. Flow %
-1.18%
Top 10 Hldgs %
30.91%
Holding
425
New
29
Increased
142
Reduced
157
Closed
18

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$26.3M
2
NDSN icon
Nordson
NDSN
+$6.48M
3
AVGO icon
Broadcom
AVGO
+$6.19M
4
COP icon
ConocoPhillips
COP
+$5.55M
5
ISRG icon
Intuitive Surgical
ISRG
+$3.83M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$19.3M
2
DE icon
Deere & Co
DE
+$5.46M
3
MSFT icon
Microsoft
MSFT
+$5.11M
4
MRCY icon
Mercury Systems
MRCY
+$4.37M
5
BABA icon
Alibaba
BABA
+$3.21M

Sector Composition

Rank Sector Weight
1 Technology 20.42%
2 Healthcare 17.37%
3 Financials 11.62%
4 Industrials 9.59%
5 Communication Services 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMP
126
DELISTED
Magellan Midstream Partners, L.P.
MMP
$4.3M 0.1%
94,268
-545
-0.6% -$25.9K
STT icon
127
State Street
STT
$51.3B
$4.26M 0.1%
50,311
-150
-0.3% -$13K
NVS icon
128
Novartis
NVS
$298B
$4.25M 0.1%
51,996
-9,648
-16% -$868K
INTC icon
129
Intel
INTC
$491B
$4.05M 0.1%
76,116
+2,721
+4% +$148K
CHWY icon
130
Chewy
CHWY
$9.25B
$4.04M 0.09%
59,324
-219
-0.4% -$18.1K
TEL icon
131
TE Connectivity
TEL
$62B
$4.02M 0.09%
29,307
+332
+1% +$47.9K
TGT icon
132
Target
TGT
$69.1B
$3.94M 0.09%
17,238
-981
-5% -$246K
BMY icon
133
Bristol-Myers Squibb
BMY
$132B
$3.89M 0.09%
65,682
+160
+0.2% +$10.5K
CME icon
134
CME Group
CME
$94.8B
$3.75M 0.09%
19,405
– –
FAST icon
135
Fastenal
FAST
$59.9B
$3.73M 0.09%
144,694
-688
-0.5% -$18.7K
CL icon
136
Colgate-Palmolive
CL
$74.3B
$3.73M 0.09%
49,372
-3,411
-6% -$271K
FDX icon
137
FedEx
FDX
$76.9B
$3.69M 0.09%
16,846
+12,701
+306% +$3.45M
QCOM icon
138
Qualcomm
QCOM
$170B
$3.69M 0.09%
28,630
+638
+2% +$90.5K
LLY icon
139
Eli Lilly
LLY
$1.1T
$3.68M 0.09%
15,941
-4,348
-21% -$1.07M
CVS icon
140
CVS Health
CVS
$122B
$3.67M 0.09%
43,214
-1,346
-3% -$113K
ADI icon
141
Analog Devices
ADI
$187B
$3.6M 0.08%
21,481
-526
-2% -$88.2K
GDX icon
142
VanEck Gold Miners ETF
GDX
$27.6B
$3.59M 0.08%
121,940
+4,273
+4% +$139K
WFC icon
143
Wells Fargo
WFC
$265B
$3.58M 0.08%
77,062
-194
-0.3% -$8.98K
NVO
144
Novo Nordisk
NVO
$211B
$3.52M 0.08%
73,258
+816
+1% +$39.4K
PANW icon
145
Palo Alto Networks
PANW
$314B
$3.47M 0.08%
43,422
+600
+1% +$42.2K
BRK.A icon
146
Berkshire Hathaway Class A
BRK.A
$1.14T
$3.29M 0.08%
8
– –
WM icon
147
Waste Management
WM
$90.6B
$3.17M 0.07%
21,234
-9
-0% -$1.35K
KEYS icon
148
Keysight
KEYS
$57.3B
$3.16M 0.07%
19,244
-1,394
-7% -$234K
GILD icon
149
Gilead Sciences
GILD
$165B
$3.09M 0.07%
44,193
+35
+0.1% +$2.46K
C icon
150
Citigroup
C
$227B
$3M 0.07%
42,743
+632
+2% +$44.2K
4 5
6
7 8

Similar funds

PCH
PGIM Custom Harvest Newark, New Jersey $6.4B AUM 18.53% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
GT
Glenview Trust Louisville, Kentucky $6.37B AUM 23.72% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return
EC
ECP ControlCo Summit, New Jersey $6.34B AUM 19.72% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return

Bradley Foster & Sargent's Q3 2021 Portfolio in Review

As of Q3 2021, Bradley Foster & Sargent held 425 positions worth $4.26B, down 0.47% from $4.28B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bradley Foster & Sargent's Q3 2021 filing shows 29 new, 142 increased, 157 reduced and 18 closed positions. Its largest new stake was Broadcom: 127,340 shares worth $6.17M. The largest sale was Vertex Pharmaceuticals, an estimated $19.3M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Bradley Foster & Sargent's largest Q3 2021 buy was Broadcom: 127,340 shares worth $6.17M.
  • Bradley Foster & Sargent added most to Oracle in Q3 2021, an estimated $26.3M increase.
  • Bradley Foster & Sargent's biggest Q3 2021 reduction was Vertex Pharmaceuticals, cutting an estimated $19.3M.
  • Bradley Foster & Sargent fully exited Mercury Systems in Q3 2021, selling an estimated $4.37M.
  • Bradley Foster & Sargent's ten largest holdings make up 31% of its $4.26B portfolio in Q3 2021.
  • Bradley Foster & Sargent opened 29 new positions and closed 18 in Q3 2021.
  • Bradley Foster & Sargent's portfolio value fell 0.47% quarter-over-quarter to $4.26B.

Based on Bradley Foster & Sargent's 13F filing for Q3 2021, filed 10 Nov 2021.